Brief: Sino Biopharmaceutical Says Acquisition Of 29.99% Equity Interest In Hob Biotech
30/10/2024 17:36
Oct 30 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* ACQUISITION OF 29.99% EQUITY INTEREST IN TARGET COMPANY
* DEAL FOR RMB630.0 MILLION
* UNIT ENTERED EQUITY TRANSFER AGREEMENT WITH HOB BIOTECH HK
* BEIJING RUNKANG AGREED TO ACQUIRE 29.99% STAKE IN HOB
BIOTECH
GROUP
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit